SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-19-016588
Filing Date
2019-08-23
Accepted
2019-08-23 16:01:43
Documents
2
Group Members
JONATHAN & NANCY GLASER FAMILY TRUST DTD 12/16/1998NANCY E. GLASERPACIFIC CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G sc13g0819a1glaser_emmaus.htm SC 13G/A 64645
2 JOINT FILING AGREEMENT sc13g0819a1ex99-1_emmaus.htm EX-99.1 4183
  Complete submission text file 0001213900-19-016588.txt   70535
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Subject) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-79934 | Film No.: 191049137
SIC: 8090 Services-Misc Health & Allied Services, NEC
Office of Life Sciences

Mailing Address 11601 WILSHIRE BLVD., SUITE 2180 LOS ANGELES CA 90025
Business Address
GLASER JONATHAN M (Filed by) CIK: 0001264694 (see all company filings)

Type: SC 13G/A